Articles with Puma Biotechnology
Puma Biotechnology Reports Third Quarter 2021 Financial Results
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology (NasdaqGS:PBYI) Stock Price & Quote Analysis - Simply Wall St
Puma Biotechnology Inc (PBYI) Pops 60% on FDA Review | InvestorPlace
米国株投資】プーマ・バイオテクノロジー(Puma Biotechnology, Inc.：PBYI) 年度ごとの財務・業績推移 | シラテブログ
Puma Biotechnology Surging
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology, Inc. 2020 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
PBYI - candlestick chart analysis of Puma Biotechnology Inc
Puma Biotechnology Reports First Quarter 2022 Financial Results
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PUMA BIOTECHNOLOGY, INC.[PBYI]のIR・有価証券報告書に基づく簡単財務分析 | ValuationMatrix
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology's (PBYI) Highest Price: $275.07 (on 09-18-2014)
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology Inc Share Price USD0.0001
Puma Biotechnology (PBYI) Stock Price, News & Info | The Motley Fool
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat | Nasdaq
Here's What Just Happened With Puma Biotechnology, Inc. (NASDAQ:PBYI) and CymaBay Therapeutics, Inc. (NASDAQ:CBAY) - Market Exclusive
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
